Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 558-564, March 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, T. T.
Right arrow Articles by Mealey, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, T. T.
Right arrow Articles by Mealey, J., Jr.

Effects of Cytosine Arabinoside and 1,3-Bis(2-chloroethyl)-1-nitrosourea on Human Glial Tumor Cells1

Tsu T. Chen and John Mealey, Jr.

Division of Neurological Surgery, Indiana University Medical Center, Indianapolis, Indiana 46202

The effects of 1-ß-D-arabinofuranosylcytosine were examined in cultures of 5 glial tumor cell strains derived from different patients. The growth inhibition by 1-ß-D-arabinofuranosylcytosine was assessed by counting the number of cells remaining in microtest plates. A significant drug effect was demonstrated against all 5 cell strains. Inhibition was dependent on dosage and duration of treatment. When doses reached the level of 0.5 {varepsilon}g/ml, however, there were no further increases in inhibitory response. The degree of recovery from growth inhibition likewise became less marked with higher dosage and longer treatment. The surviving cells remained in situ without further proliferation. The cytotoxic effect was shown to be enhanced by combination treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea (8.0 µg/ml).

1 Supported by USPHS Grant CA-06145 from the National Cancer Institute.

Received 3/24/71. Accepted 11/19/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.